18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis

Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2242-2243. doi: 10.1007/s00259-020-04844-5. Epub 2020 May 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fluorine Radioisotopes
  • Humans
  • Indoles
  • Multiple Sclerosis* / drug therapy
  • Receptors, GABA

Substances

  • 18F-GE180
  • Fluorine Radioisotopes
  • Indoles
  • Receptors, GABA
  • TSPO protein, human